Genetic Technologies Profit Margin 2006-2021 | GENE
Current and historical gross margin, operating margin and net profit margin for Genetic Technologies (GENE) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Genetic Technologies net profit margin as of June 30, 2021 is 0%.
| Genetic Technologies Annual Profit Margins |
| Genetic Technologies Quarterly Profit Margins |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.030B |
$0.000B |
|
Genetic Technologies was the first company in the world to recognize important new applications for `non-coding` DNA (DeoxyriboNucleic Acid). The Company has since been granted patents securing intellectual property rights for particular uses of non-coding DNA in genetic analysis and gene mapping across all genes in all multicellular species.
|
